Spots Global Cancer Trial Database for A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide
Official Title: Prospective, Multi-Country, Observational Study of Clinical Outcomes for Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With ADT Plus Apalutamide or Enzalutamide Under Routine Clinical Practice (ArtemisPRO)
Study ID: NCT05901649
Study Description
Brief Summary: The purpose of this study is to assess the real-world outcomes differences between apalutamide or enzalutamide plus androgen deprivation therapy (ADT) for the treatment of participants with metastatic hormone-sensitive prostate cancer (mHSPC).
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Klinikum Wels-Grieskirchen, Wels, , Austria
Akh Wien, Wien, , Austria
Institut Sainte Catherine, Avignon, , France
Institut Bergonié, Bordeaux, , France
Polyclinique Bordeaux Nord Acquitaine, Bordeaux, , France
Clinique Pasteur- Lanroze, Brest, , France
Hôpital Edouard Herriot, Lyon, , France
Centre d'oncologie de Gentilly, Nancy, , France
CHU Nîmes, Nimes, , France
Hopital Europeen Georges-Pompidou, Paris, , France
Clinique de la Croix du Sud, Quint-Fonsegrives, , France
Centre Hospitalier Prive, Saint-Grégoire, , France
Hopital Foch, Suresnes, , France
CHU de Toulouse, Toulouse cedex 9, , France
Urologie Dierdorf, Dierdorf, , Germany
St. Elisabeth Hospital Leipzig, Dresden, , Germany
Urologicum Duisburg, Duisburg, , Germany
Urologisches Zentrum Mittelhessen, Gladenbach, , Germany
Praxis Dr. Serkan Filiz, Hamburg, , Germany
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, , Germany
Universitaetsklinikum Muenster, Muenster, , Germany
Krankenhaus Barmherzige Brüder Regensburg, Regensburg, , Germany
Anticancer Oncology Hospital of Athens Agios Savvas, Athens, , Greece
General Oncology Hospital of Kifisias "Agioi Anargyroi, Athens, , Greece
University Hospital of Heraklion, Heraklion, , Greece
'Papageorgiou' General Hospital of Thessaloniki, Thessaloniki, , Greece
Hosp. Univ. A Coruna, A Coruna, , Spain
Hosp. Torrecardenas, Almería, , Spain
Hosp. Gral. Univ. de Castellon, Castellon, , Spain
Hosp. Puerta Del Mar, Cádiz, , Spain
Hosp. Univ. de Canarias, La Laguna, , Spain
Hosp. Univ. Lucus Augusti, Lugo, , Spain
Hosp. Regional Univ. de Malaga, Malaga, , Spain
Hosp. Clinico Univ. de Santiago, Santiago de Compostela, , Spain
Hosp. Univ. I Politecni La Fe, Valencia, , Spain
Frimley Health NHS Foundation Trust, Berkshire, , United Kingdom
Torbay Hospital-Devon, Devon, , United Kingdom
Royal Surrey County Hospital NHS Trust, Guildford, , United Kingdom
Pennine Care Nhs Foundation Trust, Oldham, , United Kingdom
Scunthorpe General Hospital, Scunthorpe, , United Kingdom
Contact Details
Name: Janssen-Cilag Ltd Clinical Trial
Affiliation: Janssen-Cilag Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
